Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Oncogene ; 33(5): 567-77, 2014 Jan 30.
Article in English | MEDLINE | ID: mdl-23318458

ABSTRACT

Tumor cells require increased adenosine triphosphate (ATP) to support anabolism and proliferation. The precise mechanisms regulating this process in tumor cells are unknown. Here, we show that the receptor for advanced glycation endproducts (RAGE) and one of its primary ligands, high-mobility group box 1 (HMGB1), are required for optimal mitochondrial function within tumors. We found that RAGE is present in the mitochondria of cultured tumor cells as well as primary tumors. RAGE and HMGB1 coordinately enhanced tumor cell mitochondrial complex I activity, ATP production, tumor cell proliferation and migration. Lack of RAGE or inhibition of HMGB1 release diminished ATP production and slowed tumor growth in vitro and in vivo. These findings link, for the first time, the HMGB1-RAGE pathway with changes in bioenergetics. Moreover, our observations provide a novel mechanism within the tumor microenvironment by which necrosis and inflammation promote tumor progression.


Subject(s)
Electron Transport Complex I/metabolism , HMGB1 Protein/metabolism , Pancreatic Neoplasms/pathology , Receptor for Advanced Glycation End Products/metabolism , Adenosine Triphosphate/biosynthesis , Adenosine Triphosphate/metabolism , Animals , Butadienes/pharmacology , CD24 Antigen/genetics , Cell Line, Tumor , Cell Movement , Cell Proliferation , Cycloheximide/pharmacology , Electron Transport Complex I/antagonists & inhibitors , Energy Metabolism , Enzyme Inhibitors/pharmacology , Extracellular Signal-Regulated MAP Kinases/drug effects , Extracellular Signal-Regulated MAP Kinases/metabolism , HMGB1 Protein/drug effects , Humans , Inflammation/metabolism , MAP Kinase Kinase 2/genetics , MAP Kinase Kinase 2/metabolism , Mice , Mitochondria/drug effects , Mitochondria/metabolism , NF-kappa B/drug effects , NF-kappa B/metabolism , Nitriles/pharmacology , Pancreatic Neoplasms/metabolism , Phosphorylation/drug effects , Protein Binding/drug effects , Protein Synthesis Inhibitors/pharmacology , RNA Interference , RNA, Small Interfering/genetics , Receptor for Advanced Glycation End Products/genetics , Rotenone/pharmacology , Signal Transduction , Toll-Like Receptor 2/genetics , Toll-Like Receptor 4/genetics , Tumor Microenvironment , Uncoupling Agents
SELECTION OF CITATIONS
SEARCH DETAIL